A full product pipeline is vital for technology, biotechnology, and life sciences organizations to survive competitor encroachment. To succeed, companies must continually launch product improvements while reducing the commercialization costs and risks.
Keep it Simple
While comprehensive New Product Development (NPD) systems exist, their structural complexity often causes implementation failure at the grassroots level without constant senior oversight. BioPlan Associates provides a straightforward, customer-oriented, cost-effective alternative for marketing and product managers.
Benefits of an optimized NPD process:
- First-to-Market Advantage: Launch successful products while competitors rely on hit-or-miss R&D.
- Accelerated Timelines: Increase your success rate and get products out the door faster than rivals.
- Streamlined Decisions: Eliminate non-productive internal debates by creating a customer-driven R&D process.
- Improved Teamwork: Enhance internal alignment, communication, and management through clear, market-validated targets.
New Product Development Issues
When developing new products, technology-driven firms frequently overlook or incorrectly estimate critical baseline variables:
- Market Dynamics: Is the market size, adoption velocity, and capture volume attractive enough to justify the investment?
- Customer & Profitability: Is there a verified need, who is the actual decision-maker, and can we reach revenue goals profitably?
- Opportunity Costs & Tech: Could NPD resources be allocated to a better project, and will competing technologies leapfrog the product before launch?
Reduce the Risk in New Product Development
BioPlan Associates helps manage and control critical exposure points across the organization:
- Concept Risk: Evaluating the statistical probability of financial success rather than relying on a good idea.
- Process Risk: Establishing strict operational controls to manage the development cycle.
- Internal Coordination Risk: Aligning multiple departments to prevent communication breakdowns.
- Evaluation Risk: Ensuring market acceptance data is reliable, accurate, and valid.
Why New Products Fail
- No Rigorous Process: Failing to accurately assess overall market demand, development/production costs, and competitor reactions.
- "Over-Championing": Occurs when an executive or product manager pushes a favorite project without data-backed checks, balances, or market validation.
- Poor Marketing Execution: Failing due to weak commercial launch strategies, inaccurate pre-market testing, or a failure to meet the technical specifications the market demands.
Simple 8-Step New Product Development Process
This replicable process covers the major milestones required to launch a product:
Ideation: Source targeted concepts from customers, competitors, suppliers, and internal staff.
Idea Screening: Filter concepts by market potential, competition, internal capabilities, IP, and financial constraints.
Concept Testing: Confirm the product solves a customer problem better than existing alternatives.
Market Strategy: Define long-term commercial goals and marketing-mix strategies.
Business Analysis: Evaluate sales projections, revenue potential, and break-even metrics.
Product Development: Resolve technical bottlenecks, manufacturing scale-up, and logistics.
Market Testing: Beta-test in isolated markets to catch flaws before full deployment.
Commercialization: Launch to the broader market with targeted messaging.
New Product Development Quick Test
To determine your product's actual viability, calculate its overall probability of success using this formula:
The Formula:
- % Probability of technical completion
- X % Probability of commercialization
- X % Probability of market acceptance and profitability
- = % Likelihood of a Successful Product Launch
Example (DNA Purification System):
- 90% Likelihood that the concept works technically
- X 80% Likelihood of cost-effective commercial production
- X 80% Likelihood of market acceptance and profitability
- = 58% Probability of Launch Success
The Reality Check: Evaluate if your senior management or investors can accept these odds. A 58% probability means you face a near 50/50 chance of commercial failure.
Identify which variable in the equation you must change to shift the odds in your favor. Pinpointing and optimizing these weak spots allows you to preempt project failure before deploy. Regardless of your final percentage, mitigating these variables requires a rigorous, data-backed new product development model.
